Summary: Clinical Epidemiology | 9781451144475

Summary: Clinical Epidemiology | 9781451144475 Book cover image
  • This + 400k other summaries
  • A unique study and practice tool
  • Never study anything twice again
  • Get the grades you hope for
  • 100% sure, 100% understanding
PLEASE KNOW!!! There are just 58 flashcards and notes available for this material. This summary might not be complete. Please search similar or other summaries.
Use this summary
Remember faster, study better. Scientifically proven.
Trustpilot Logo

Read the summary and the most important questions on Clinical Epidemiology | 9781451144475

  • 9 Treatment

    This is a preview. There are 20 more flashcards available for chapter 9
    Show more cards here

  • Why are rct's build up like that?

    The validity of clinical trials depends on how well they have created equal distribution of all determinants of prognosis, other than the one being tested.
  • Why are there such strict inclusion and exclusion criteria in an rct?

    To increase homogeneity
    Strengthen internal validity
    make it easier to distinguish signal  from the noise
  • Why are patients with comorbidities often excluded?

    Because the care and outcome of these other diseases can muddy the contrast between experimental and comparison treatments and their outcomes.
  • What are three important questions you need to ask before researching an intervention?

    1. Is the intervention likely to be implemented in clinical practice
     2. Does it reflect the normal complexity of real-world treatment
     3. Is it sufficiently different from alternative treatment.
  • What is the strength of having a no-treatment group?

    The total effect of the treatment can be assessed.
  • What are baseline characteristics?

    The characteristics present in the group before randomization. These should be equally distributed in the treatment groups.
  • What is stratified randomization? Why would you use it?

    In small trials, to reduce bad luck it is best to make sure that at least some of the characteristics known to be strongly associated with outcome occur equally in treated and control patients.
     
    Patients are gathered into strata (groups) that have similar levels of a prognostic factor. From there control and treatment are made. Which can be piled together at the end of the study.
  • At which four levels can blinding take place?

    Allocation concealment- the people responsible for random allocation should not know which treatment will be assigned next
     Patients- should be unaware of the treatment
     Physicians should not know which treatment each patient is on
     The researchers who assess the outcome
  • What is an open trial?

    When no attempt at blinding is done
  • What are effectiveness trials?

    Does offering treatment work under ordinary circumstances. Describes results as most patients would experience them
PLEASE KNOW!!! There are just 58 flashcards and notes available for this material. This summary might not be complete. Please search similar or other summaries.

To read further, please click:

Read the full summary
This summary +380.000 other summaries A unique study tool A rehearsal system for this summary Studycoaching with videos
  • Higher grades + faster learning
  • Never study anything twice
  • 100% sure, 100% understanding
Discover Study Smart

Topics related to Summary: Clinical Epidemiology